Literature DB >> 34155353

Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selection.

Arzu Cakir1, Melisa Tuncer1, Hilal Taymaz-Nikerel1, Ozlem Ulucan2.   

Abstract

One in every ten drug candidates fail in clinical trials mainly due to efficacy and safety related issues, despite in-depth preclinical testing. Even some of the approved drugs such as chemotherapeutics are notorious for their side effects that are burdensome on patients. In order to pave the way for new therapeutics with more tolerable side effects, the mechanisms underlying side effects need to be fully elucidated. In this work, we addressed the common side effects of chemotherapeutics, namely alopecia, diarrhea and edema. A strategy based on Random Forest algorithm unveiled an expression signature involving 40 genes that predicted these side effects with an accuracy of 89%. We further characterized the resulting signature and its association with the side effects using functional enrichment analysis and protein-protein interaction networks. This work contributes to the ongoing efforts in drug development for early identification of side effects to use the resources more effectively.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34155353     DOI: 10.1038/s41397-021-00246-4

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  61 in total

1.  Trends in clinical success rates and therapeutic focus.

Authors:  Helen Dowden; Jamie Munro
Journal:  Nat Rev Drug Discov       Date:  2019-07       Impact factor: 84.694

Review 2.  A review of connectivity map and computational approaches in pharmacogenomics.

Authors:  Aliyu Musa; Laleh Soltan Ghoraie; Shu-Dong Zhang; Galina Glazko; Olli Yli-Harja; Matthias Dehmer; Benjamin Haibe-Kains; Frank Emmert-Streib
Journal:  Brief Bioinform       Date:  2018-05-01       Impact factor: 11.622

3.  Clinical development success rates for investigational drugs.

Authors:  Michael Hay; David W Thomas; John L Craighead; Celia Economides; Jesse Rosenthal
Journal:  Nat Biotechnol       Date:  2014-01       Impact factor: 54.908

4.  Drug-induced adverse events prediction with the LINCS L1000 data.

Authors:  Zichen Wang; Neil R Clark; Avi Ma'ayan
Journal:  Bioinformatics       Date:  2016-04-01       Impact factor: 6.937

Review 5.  In silico methods for drug repurposing and pharmacology.

Authors:  Rachel A Hodos; Brian A Kidd; Khader Shameer; Ben P Readhead; Joel T Dudley
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-04-15

6.  A gene expression signature that predicts the future onset of drug-induced renal tubular toxicity.

Authors:  Mark R Fielden; Barrett P Eynon; Georges Natsoulis; Kurt Jarnagin; Deborah Banas; Kyle L Kolaja
Journal:  Toxicol Pathol       Date:  2005       Impact factor: 1.902

7.  Data mining in the Life Sciences with Random Forest: a walk in the park or lost in the jungle?

Authors:  Wouter G Touw; Jumamurat R Bayjanov; Lex Overmars; Lennart Backus; Jos Boekhorst; Michiel Wels; Sacha A F T van Hijum
Journal:  Brief Bioinform       Date:  2012-07-10       Impact factor: 11.622

Review 8.  Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review.

Authors:  David B Fogel
Journal:  Contemp Clin Trials Commun       Date:  2018-08-07

9.  A transcriptomics data-driven gene space accurately predicts liver cytopathology and drug-induced liver injury.

Authors:  Pekka Kohonen; Juuso A Parkkinen; Egon L Willighagen; Rebecca Ceder; Krister Wennerberg; Samuel Kaski; Roland C Grafström
Journal:  Nat Commun       Date:  2017-07-03       Impact factor: 14.919

10.  Improving the odds of drug development success through human genomics: modelling study.

Authors:  Aroon D Hingorani; Valerie Kuan; Chris Finan; Felix A Kruger; Anna Gaulton; Sandesh Chopade; Reecha Sofat; Raymond J MacAllister; John P Overington; Harry Hemingway; Spiros Denaxas; David Prieto; Juan Pablo Casas
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.